Compare Alcon AG (ALC) vs Asana Inc. (ASAN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Asana Inc. — how do they compare? Alcon AG trades at $66.87 (market cap $32.69B), while Asana Inc. trades at $7.14 (market cap $1.73B). The key difference: Alcon AG is far larger — about 18.9× Asana Inc.'s market cap, and Alcon AG pays a 0.54% dividend while Asana Inc. pays none. Which is the better fit depends on your goals.
| ALC | ASAN | |
|---|---|---|
Market Cap | $32.69B | $1.73B |
Sector | Health | Consumer Cyclical |
52-Week High | $92.22 | $15.35 |
52-Week Low | $62.02 | $5.46 |
Enterprise Value | $36.28B | $1.55B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Asana (ASAN) trades at $7.49, up 2.04% with bullish technical momentum and consistent earnings beats. The company shows strong revenue growth from $378M in 2022 to $724M in 2025, though profitability remains negative with a -20.21% net margin. Recent developments include the StackAI acquisition and FedRAMP authorization, positioning Asana in the AI workflow automation space. Analyst consensus is mixed with a $9.86 price target representing 32% upside potential from current levels.
The outlook balances growth potential against persistent losses. Revenue expansion and AI integration offer upside, but negative margins and cash flow volatility present significant execution risks. With the stock trading near analyst targets and mixed institutional sentiment, investors face a high-risk, high-reward scenario requiring careful monitoring of profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Asana Inc.
Asana Inc is a software company. The company provides a platform for work management that helps teams orchestrate work, from daily tasks to cross-functional strategic initiatives. It helps plan marketing campaigns, streamlines processes, manages sales, and manage product launches. Also, the company provides project management and workflow management solutions.
Read more on ASAN →
